Related Experiment Video
Updated: May 13, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink
Olesya A Ulanovskaya1, Andrea M Zuhl, Benjamin F Cravatt
1The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, USA.
Abstract:
Nicotinamide N-methyltransferase (NNMT) is overexpressed in a variety of human cancers, where it contributes to tumorigenesis by a mechanism that is still poorly understood. Here we show using metabolomics that NNMT impairs the methylation potential of cancer cells by consuming methyl units from S-adenosyl methionine to create the stable metabolic product 1-methylnicotinamide. As a result, NNMT-expressing cancer cells have an altered epigenetic state that includes hypomethylated histones and other cancer-related proteins combined with heightened expression of protumorigenic gene products. Our findings thus point to a direct mechanistic link between the deregulation of a metabolic enzyme and widespread changes in the methylation landscape of cancer cells.
Insights
Nicotinamide N-methyltransferase (NNMT) overexpression in cancer depletes methyl groups, altering cell epigenetics. This metabolic disruption promotes tumor growth by affecting gene expression and protein methylation.
Area of Science:
- Biochemistry
- Cancer Biology
- Epigenetics
Background:
- Nicotinamide N-methyltransferase (NNMT) is frequently overexpressed in various human cancers.
- The precise mechanism by which NNMT contributes to tumorigenesis remains incompletely understood.
Purpose of the Study:
- To elucidate the mechanistic link between NNMT overexpression and cancer development.
- To investigate the impact of NNMT on cellular methylation potential and epigenetic modifications.
Main Methods:
- Metabolomic analysis was employed to study the metabolic consequences of NNMT activity.
- Changes in histone and protein methylation were assessed in NNMT-expressing cancer cells.
Main Results:
- NNMT was found to consume methyl units from S-adenosyl methionine, producing 1-methylnicotinamide.
- NNMT overexpression led to hypomethylated histones and other proteins in cancer cells.
- Heightened expression of protumorigenic genes was observed in conjunction with NNMT activity.
Conclusions:
- NNMT deregulation directly impacts the cellular methylation landscape.
- NNMT contributes to tumorigenesis by altering epigenetic states and promoting protumorigenic gene expression.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

